These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8350430)

  • 1. Cryopreserved venous allografts: effects of immunosuppression and antiplatelet therapy on patency and function.
    Miller VM; Bergman RT; Gloviczki P; Brockbank KG
    J Vasc Surg; 1993 Aug; 18(2):216-26. PubMed ID: 8350430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryopreservation affects endothelial and smooth muscle function of canine autogenous saphenous vein grafts.
    Elmore JR; Gloviczki P; Brockbank KG; Miller VM
    J Vasc Surg; 1991 May; 13(5):584-92. PubMed ID: 2027197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional changes in canine saphenous veins after cryopreservation.
    Elmore JR; Gloviczki P; Brockbank KG; Miller VM
    Int Angiol; 1992; 11(1):26-35. PubMed ID: 1522350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cryopreserved allograft venous conduits in dogs.
    Deaton DW; Stephens JK; Karp RB; Gamliel H; Rocco F; Perelman MJ; Liddicoat JR; Glick DB; Watkins CW
    J Thorac Cardiovasc Surg; 1992 Jan; 103(1):153-62. PubMed ID: 1728702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dietary L-arginine on structure and function of flow-restricted vein grafts.
    Landis ME; Ray EC; Gloviczki P; Miller VM
    J Vasc Surg; 2001 Apr; 33(4):829-39. PubMed ID: 11296339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suggested treatment protocol for improving patency of femoral-infrapopliteal cryopreserved saphenous vein allografts.
    Buckley CJ; Abernathy S; Lee SD; Arko FR; Patterson DE; Manning LG
    J Vasc Surg; 2000 Oct; 32(4):731-8. PubMed ID: 11013037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of cryopreserved veins. Preliminary report.
    Brockbank KG; Donovan TJ; Ruby ST; Carpenter JF; Hagen PO; Woodley MA
    J Vasc Surg; 1990 Jan; 11(1):94-100; discussion 100-2. PubMed ID: 2296107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryopreservation alters antigenicity of allografts in a porcine model of transplant vasculopathy.
    Solanes N; Rigol M; Castellà M; Khabiri E; Ramírez J; Segalés J; Roqué M; Agustí E; Pérez-Villa F; Roig E; Pomar JL; Sanz G; Heras M
    Transplant Proc; 2004 Dec; 36(10):3288-94. PubMed ID: 15686747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human saphenous vein grafts explanted from the arterial circulation demonstrate altered smooth-muscle and endothelial responses.
    Park TC; Harker CT; Edwards JM; Moneta GL; Taylor LM; Porter JM
    J Vasc Surg; 1993 Jul; 18(1):61-8; discussion 68-9. PubMed ID: 8326660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of cryopreserved canine venous allografts.
    Bank HL; Schmehl MK; Warner R; Pratt MF; Albernaz MS; Metcalf JS; Darcy M
    J Surg Res; 1991 Jan; 50(1):57-64. PubMed ID: 1987432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlling transplant vasculopathy in cryopreserved vein grafts with polyethylene glycol and glutathione during transport.
    Davies MG; Huynh TT; Fulton GJ; Svendsen E; Brockbank FG; Hagen PO
    Eur J Vasc Endovasc Surg; 1999 Jun; 17(6):493-500. PubMed ID: 10375485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early results of infrageniculate arterial reconstruction using cryopreserved homograft saphenous conduit (CADVEIN) and combination low-dose systemic immunosuppression.
    Posner MP; Makhoul RG; Altman M; Kimball P; Cohen N; Sobel M; Dattilo J; Lee HM
    J Am Coll Surg; 1996 Sep; 183(3):208-16. PubMed ID: 8784313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary arterial reactivity after transplantation. Differential effects of denervation and rejection.
    Nilsson FN; McGregor CG; Miller VM
    J Thorac Cardiovasc Surg; 1992 Apr; 103(4):751-61; discussion 761-2. PubMed ID: 1548917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular repopulation of human vein allograft bypass grafts.
    Johnson TR; Tomaszewski JE; Carpenter JP
    J Vasc Surg; 2000 May; 31(5):994-1002. PubMed ID: 10805891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryopreserved vein transplantation.
    Brockbank KG; McNally RT; Walsh KA
    J Card Surg; 1992 Jun; 7(2):170-6. PubMed ID: 1606369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lumbar sympathectomy on the properties of both endothelium and smooth muscle cells of the canine femoral artery and autogenous vein grafts under poor runoff conditions.
    Funahashi S; Komori K; Itoh H; Okadome K; Sugimachi K
    J Surg Res; 1996 Aug; 64(2):184-9. PubMed ID: 8812631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allograft vein patency in a canine model. Additive effects of cryopreservation and cyclosporine.
    Augelli NV; Lupinetti FM; el Khatib H; Sanofsky SJ; Rossi NP
    Transplantation; 1991 Sep; 52(3):466-70. PubMed ID: 1897018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimethylsulfoxide-treated, cryopreserved venous allografts in the arterial and venous systems.
    Sitzmann JV; Imbembo AL; Ricotta JJ; McManama GP; Hutchins GM
    Surgery; 1984 Feb; 95(2):154-9. PubMed ID: 6695333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of cryopreserved arterial allografts under immunosuppressive protection with cyclosporine A.
    Vischjager M; Van Gulik TM; Van Marle J; Pfaffendorf M; Jacobs MJ
    J Vasc Surg; 1996 Nov; 24(5):876-82. PubMed ID: 8918337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive treatment of venous allografts.
    Vermassen F; Degrieck N; De Kock L; Goubeau J; Van Landuyt K; Noens L; Derom F
    Eur J Vasc Surg; 1991 Dec; 5(6):669-75. PubMed ID: 1836770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.